Categories
Connect with us on LinkedIn
2023: Castor Year in Review
As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric...
Creating Real World Evidence: Researching the impact of medical AI on a global scale
Castor’s clinical trial platform supports Ada Health’s research goals with patient-friendly surveys, easy-to-build eCRFs, and a flexible, compliant...
The AI Hype and Reality: Key Highlights from CNS Summit 2023
At this year's CNS Summit, Castor achieved a remarkable feat by winning the AI Demo Awards. Watch more...
10 FAQs on eConsent
To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address...
What to expect at the CNS Summit Live AI Demo
As the world works towards a future of AI-assisted solutions, we believe that everyone who is involved in...
Product Spotlight: Dive deep into Castor’s eConsent
This product spotlight webinar will help you gain a deeper understanding of Castor’s eConsent capabilities for patients, sponsors...
Don’t Overengineer It: Hybrid Designs Overcome Barriers in DTx Clinical Trials
At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials
Understand Barriers to eConsent Adoption from Site and Sponsor Perspectives
Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.
A Digital-First Mindset Shift on eConsent
eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical...
Navigating successful eConsent adoption from sponsor to site
Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent...
Preparing for Post-Market Clinical Follow-Up Under EU MDR
Download our White Paper: Preparing for Post-Market Clinical Follow-up (PMCF) under EU MDR (European Union Medical Device Regulation)...
Harnessing the power of Patient-centric Technologies
Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.
Castor announces Frans van Houten, former CEO of Philips, as the company’s new chairman of its Board Of Directors
His exceptional leadership experience and extensive industry knowledge in the healthcare and technology industries will be invaluable to...
Preparing Your eConsent Study for IRB Approval
In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare...
Essity uses Castor eConsent to optimize enrollment
Essity partnered with Castor and Link2Trials to develop a hybrid trial ecosystem that was accessible to all participants.
Castor welcomes Jeanne Hecht to Board of Directors
Castor, an industry leader in modular, patient-centric, clinical trial technology, today announced the appointment of Jeanne Hecht to...
Product Spotlight: Castor ePRO
In this on-demand webinar we dive into the benefits and capabilities of ePRO, and how Castor’s web and...
AI & Air Hockey – What to expect at DIA?
Listen to our CEO & Founder, Derk Arts, as he reflects on lessons learned from the BIO panel...
Connect with us on LinkedIn
